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ABSTRACT 
This study investigated Crossoptyerx  febrifuga stem bark extract for antihyperglycemic and antihyperlipidemic 
effects in alloxan–induced diabetic rats. Thirty diabetic albino rats were assigned into six groups of five rats 
each and treated with extract of varying doses (500mg/kg, 1000mg/kg and 1500mg/kg) and standard antidiabetic 
drug- glibenclamide. Treatment of the diabetic rats was done in seven days through orogastric procedure. The 
extract showed a significant (p ˂ 0.05) hypoglycemic and hypolipidemic effect in all the doses compared to the 
diabetic control and standard antidiabetic drug, glibecamide. The high density lipoprotein (HDL) increased 
significantly (p ˂ 0.05) and the low density lipoprotein (LDL) decreased in all the groups, as against the diabetic 
control. On percent scale, the HDL increased by 55.18% and the LDL reduced significantly (p ˂ 0.05) by 
73.52% at the dose of 500mg/kg as against the standard drug which showed just 20.69% reduction. Acute 
toxicity study was done prior to the diabetic study. The method adopted was that of Lorke and plant extract was 
found to be safe up to the dose of 5000mg/kg. Phytochemical screening revealed the presence of alkaloids, 
tannins, saponnins, cardiac glycosides, flavonoids phytosterols and polyhenolics. The presence of these rich 
phytoconstituents was the reason for the antihyperglycemic and hypolipidemic property of this plant thus, 
confirming its use in folklore. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder 
characterized by hyperglyseamia resulting from 
defect in insulin secretion and insulin inaction 
(Kangralkar et al. 2010; Adoum et.al. 2012). It is a 
disease with worldwide significance and increasing 
prevalence because of its impact on health, quality 
of life and life expectancy of patients as well as 
health care system (Amos et al. 1997; Subbiah et 
al. 2006). This disease affects millions of people 
worldwide and the number of patients increasing 
by the day with a population projected to be about 
592 million or more by the year 2035 (Guariguata 
et al.  2013). 
Besides hyperglycemia, several other 
factors like hyperlipidemia and enhanced oxidative 
stress play a major role in diabetic pathogeneses 
(Seikat et al. 2008). The elevated reactive oxygen 
species and the simultaneous decline in 
antioxidative defense mechanisms promote the 
development of late complications such as ulcer, 
blindness, neuropathy and renal failure (Eden, 
2009). Diabetes produces disturbance in lipid 
metabolism that is evident as hyperlipidemia and 
cholesterolemia- a risk factor for atherosclerosis 
(Schwartz, 2006; Li, 2007). 
In different regions of the world 
particularly Africa and Asia, plant materials have 
played an important role in the traditional 
management of diabetes mellitus and herbal 
remedies continue to be more accessible and 
affordable than conventional drugs and represent 
the first line of treatment available to diabetic 
patients especially in the rural communities (Eze et 
al. 2012). Today many researchers across the globe 
have demonstrated the role of medicinal plants in 
the control of hyperglycemia and hyperlipidemia 
(Subbiah et al. 2006; Rajagopal and Sasikaka, 
2008). 
Crossopteryx  febrifuga, a plant of the 
family Rubiaceace is widely reported for its 
medicinal value (Maiga et al. 2006; Salawu et al. 
2008). The plant is a deciduous savanna tree, 1.8-
15 meter tall, with a rounded crown and pendulum 
branches. The bark is pale grey to dark brown. It is 
widely distributed throughout West and tropical 
Africa.  C. febrifuga is known as Ikwargh gbande 
by the Tiv tribe of North Central Nigeria. It is 
called Ayeye among the Yorubas of Southwest and 
Kasifiya by the Hausas of the Northern Nigeria 
(Agishi, 2010). The plant is widely used 
traditionally for the treatment of dry cough, 
respiratory disease, fever, dysentery, pains and 
malaria (Audu, 1989; Odugbemi, 2008; Salawu et 
al. 2008).  
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A lot of scientific evidences have emerged 
to support the tradomedicinal use of C. febrifuga as 
herbal remedies. Thus, the methanol crude extract 
of the root of the plant was reported to contain 
bioactive substances with potential values in the 
treatment of trypanosomiasis, malaria and 
stafhaurcus infection (Hostettman et al. 2000; 
Yusuf et al. 2004). The root bark and leaf extract 
was also reported to have analgesic, 
antiinflammatory, antipyretic, antimalaria, 
antidiabetic and antilipidemic activities (Salawu et 
al. 2008; Ojewale et al. 2014; Ajayi et al. 2016). 
Antipyretic activity of aqueous stem bark extract of 
this plant was reported by Elisee et al. (2018). Even 
though other parts of this plant had been explored 
for its antihyperglycemic and antilipidemic 
activity, there is no scientific report so far on the 
hypoglycemic and hypolipidemic activity of its 
stem bark. And in view of the fact that different 
part of plant may contain different classes of 
natural products, this research work was carried out 
to evaluate the phytochemical constituents of 
ethanol stem bark crude extract of C. febrifuga as 
well as its hypoglycemic and hypolipidemic effects 
on alloxan-induced diabetic rats. 
 
MATERIALS AND METHODS 
Materials 
Deionised water, Centrifuge (Denley 
B5400 centrifuge, England), Micropipette, 
Weighing balance, Jenway 6310 
Spectrophotometer, Rotary evaporator (Buchi 
Vacuum Control V-850: Rotavapor, R-210, 
Germany), Normal saline and Glibenclamide, 
Accu-check Active Glucometer (Roche Diabetes 
Care GmbH, Standhofer Strasse 11668305 
Mannheim, Germany), Absolute ethanol 99.9% 
(JBH). All chemical were of analytical grade. 
 
Plant Collection 
The stem bark of Crossopteryx febrifuga 
was collected from wild in Mbalumun-Nanev, 
Kwande Local Government Area of Benue State, 
Nigeria. The plant was authenticated by Joseph 
Waya of Botany Department, Benue State 
University Makurdi where the specimen’s voucher 
no: 232 was deposited in the Herbarium unit. 
 
METHODS 
Preparation and Extraction of Plant Extract 
The stem bark of C. febrifuga was 
chopped and air dried under shade in the natural 
way for one month. The dry sample was crushed to 
powder using a mortar and pestle. 600g of the 
powdered sample was macerated in two liters (2l) 
of ethanol with occasional shaking for 3 days 
(72hrs). The mixture was decanted and filtered 
using Whatmann number one filter paper through 
vacuum filtration procedure. The filtrate was 
concentrated using computerized rotary evaporator 
at 40oC. It was finally evaporated to dryness under 
standard conditions of temperature and pressure 
and the dried extract kept in the refrigerator for use. 
 
Experimental Animals 
Wistar strain albino rats of both sexes 
(120-200) were purchased from the animal holding 
unit Central Diagnostic division of the National 
Veterinary Research Institute of Nigeria VON, 
Plateau State. The animals were kept in standard 
cages at room temperature and 12hrs daylight cycle 
for two weeks (to acclimatize) in the animal house 
at the Pharmacology Department, Bayero 
University Kano. These animals were fed freely on 
commercial feed (Vital Feed) and water. 
 
Phytochemical Screening 
Qualitative phytochemical screening of 
the stem bark extract was done using standard 
procedure (Amita and Shalini, 2014; Chukwuma 
and Chigozie, 2016). 
 
Experimental design 
This research work was organized into 3 
phases: I, II and III. Phase I was done according to 
the method of Lorke (1983) to determine the Lethal 
Dose LD50 of the extract. Phase II constituted the 
antidiabetes studies. Thirty diabetic albino rats 
were assigned into six groups of five (5) rats each 
and treated according to the schedule below (Table 
1). Treatment was done once daily by orogastric 
intubation for seven (7) days. The third III phase 
was the collection and preparation of serum sample 
for lipid profile. 
 
Table1 Experimental Design and Treatment Schedule for Anti-diabetic Study. 
Group   Description  Treatment/Drug    Dose(mg/kg) 
A  Normal/positive control  Normal saline    - 
B  Diabetic/negative control               Normal saline    -                     
C  Diabetic treated   C. febrifuga extract   500 
D  Diabetic treated   C.febrifuga extract   1000 
E  Diabetic treated   C.febrifuga extract   1500 
F  Diabetic treated   Standard drug (Glibenclamide)  5 
 
Acute Toxicity 
Modify method of lorke (1983) was used. 
Nine (9) albino rats of either sex were divided into 
3 groups of 3 rats each. In the first phase, they were 
administered orally with extract at a single dose of 
500mg/kg, 1000 mg/kg and 1500 mg/kg 
respectively and observed for 24 hrs for signs of 
toxicity and death. In the second phase, another 3 
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groups of 1 rat each were given a single dose of 
2500 mg/kg, 3500 mg/kg and 5000 mg/kg 
respectively and were observed for 24hrs for signs 
of toxicity and death. 
 
Induction of Diabetes mellitus 
The rats were subjected to 12hrs fast. 
Diabetes mellitus was then induced by 
interpretoneal injection(ip) of 150 mg/kg body 
weight of alloxan reconstituted in normal saline 
(0.9%) after fasting blood sugar (78-100mg/dl) 
were taken. The rats were left on 5% glucose to 
prevent hypoglycemia (Stanley and Venugopal, 
2001). Forty eight hours later, diabetes was 
confirmed in the rats that had blood glucose level 
equal to or greater than 230mg/dl. 
 
Treatment of Diabetes Rats and Determination 
of Blood Glucose Level, (BGL) 
The diabetes rats were sorted out and 
treated as outlined in the experimental design 
above. Treatment was done orogastrically for 
Seven days with a single dose given per day. Blood 
sample for the sugar level determination was 
collected from the tail tip by aid of lancet at 24hrs 
interval of each treatment made. The blood sugar 
levels were measured by the glucose- oxidase 
principle (Beach and turner, 1958) using one Touch 
Basic Accu-check (active) Glucometer test strips.  
Results were reported as mg/dl (Rheney and kirk, 
2000). 
 
Collection and Preparation of Serum Sample for 
Lipid Profile Analysis 
Blood samples were collected from 
overnight fasted rats via cardiac puncture with 
sterile syringe into plain tubes and were allowed to 
clot. Thereafter, the serums were separated by 
centrifugation using Denley B5400 centrifuge 
(England) at 3000rpm for 10 minutes. The serums 
(supernatants) were collected and then assayed for 
lipid profile. 
 
Lipid Profile Assay 
This was done spectrophotometrically, using 
enzymatic colorimetric assay kits (Randox, 
Northern Ireland) as follows: 
(a) Serum Total Cholesterol (TC): The serum 
total cholesterol was quantified after 
enzymatic hydrolysis and oxidation of the 
sample as described by the method of 
Stein (1987). 
(b) Serum Triglyceride (TG): This was 
determined after enzymatic hydrolysis of 
the sample with lipase as described by the 
method of Tietz (1990). 
(c) Serum High density Lipoprotein 
Cholesterol (HDL-C): This was measured 
by the method of Wacnic and Albert 
(1972). 
(d) Serum Low Density Lipoprotein 
Cholesterol, LDL-C: This was determined 
according to protocol of Friedewald et al. 
(1972).  All measurements were made in 
mg/dl. 
 
Statistical Analysis of Data 
Data obtained were expressed as Mean ± 
SEM and analyzed using the Analysis of Variance 
‘ANOVA’ via the Statistical Package for Social 
Scientists, SPSS Version 21. Values at p ˂ 0.05 




Table 2 Phytochemical constituents of the crude ethanol stem bark Extract of Crossopteryx febrifuga. 
Phytochemicals                                                                                Remarks 
 
Flavonoids                                                                                               + 
Tannins                                                                                                    + 
Saponnins                                                                                                + 
Alkaloids                                                                                                 + 
Cardiac glycosides                                                                                  + 
Phenols/polyphenols                                                                               + 
Phytosterols                                                                                             + 
Anthraquinones                                                                                       +     
  Key: (+) means detected  
 




Table 3 Effect of Ethanol Stem Bark Extract of C. febrifuga on Blood Glucose Level (mg/dl) of Diabetic Rats 
Group  Day0               Day1                 Day2                    Day3                 Day4                     Day5               Day6                          Day7 
A     78.75±4.89      78.75±4.85       77.25±4.66         76.50±4.03          81.00±2.12        90.00±3.72      89.21±2.05               90.01±3.75 
B    334.25±17.55  379.00±9.42     420.75±20.13     450.75±17.67     447.00±19.66     515.00±8.53     516.23±10.50          514.00±7.53 
C    519.50±9.08     458.75±18.55b  393.00±24.70 b  346.50±16.88 ab   294.60±12.35 ab  225.01±9.50 ab  151.50±18.26 ab    113.75±7.25 ab 
D   325.00±39.68  460.75±34.01b     515.25±12.02     470.75±23.71      421.50±24.95     381.25±19.08 a   321.40±14.53 a      275.52±11.51 a 
E   405.00±55.22   495.75±41.00 a   480.50±28.44 a  466.50±21.55 a    436.11±19.63     408.25±12.54 a   365.23±14.45 a      329.25±15.33 a 
F  552.50±9.25    568.75±7.57 a     501.12±13.65 a   469.75±19.88 a   419.67±15.60    369.00±10.68 a    342.58±30.05 a       294.75±4.23 a 
Result is significant at p˂ 0.05 and expressed as mean ± SEM; n=5, a = significant compared to diabetic control; b = significant compared to standard drug. A= 
Normal control/Positive control; B = Diabetic control; C= Diabetic treated (500mg/kg); D = Diabetic treated (1000mg/kg); E= Diabetic treated (1500mg/kg); F= 
Standard drug (glibenclamide, 5mg/kg) (student t-test) 
 




Table 4 Effect of the Ethanol Stem Bark Extract of C. febrifuga on the Lipid Profiles of Diabetic Rats. 
Group                                          Cholesterol,mg/dl          Triglyceride,mg/dl           HDL,mg/dl         LDL,mg/dl   
Positive control                         51.71±0.81b              178.78±0.51                    63.12±0.60               77.31±1.91 
Diabetic control                        95.48±0.56c              190.16±4.08                    56.81±0.10                87.50±0.55 
Diabetic treated(500mg/kg)      81.02±0.64c             117.81±15.24cb                71.47±0.49                23.17±0.29acb 
Diabetic treated(1000mg/kg)    73.15±0.18              132.32±0.21cb                  88.16±0.21cb             41.83±0.26cb 
Diabetic treated(1500mg/kg)    63.53±3.66b            149.86±6.21                    75.12±1.44cb             48.89±2.23cb 
Standard drug(5mg/kg)            54.12±0.23b             170.20±0.76                     67.37±0.28                69.40±0.24cb 
Results is expressed as mean ± SEM (n=5) and significant at p ˂ 0.05; a= significant compared to standard drug; 
b= significant compared to diabetic control; c= significant compared to positive control. 
 
RESULTS AND DISCUSSION 
Phytochemical analysis of ethanol stem 
bark extract of Crossopteryx febrifuga  revealed the 
present of  flavonoids, tannins saponnins, alkaloids, 
cardaic glycosides, phenols, phylosterols and 
anthraquinones as shown in Table 2. This result is 
in line with the work reported by Salawu et al. 
(2008) on the methanol leaf extract and Ojewale et 
al. (2014) on methanol root extract of the plant 
respectively. These classes of phytochemicals have 
been implicated for antihyperglycemic properties 
(Switi et al. 20014). Previous studies have shown 
that glycosides for instance have inhibitory effect 
on alpa-amylase, aldose reductase, alpha-
glucosidase and could increase the level of serum 
insulin. In addition, flavonoids, beside their 
antioxidant properties, reduce glucose transporter 
(Cazarolli et al. 2008; Switi et al. 2014). Alkaloids 
do have a stimulatory action on insulin secretion by 
activation of imidazole I binding sites in the 
pancreatic β-cell ( Ujah et al. 2015). Thus, these 
phytochemicals in synergy or unilaterally, could 
have contributed to improving insulin secretion and 
action on the glycemic level. Hence the rationale 
for C. febrifuga stem bark extract exerting 
hypoglycemic effect (Table 3) in the alloxan-
induced diabetic rats and its use in the management 
of diabetes mellitus by folklore.   
Phytotoxicity study showed that there was 
no sign of toxicity in the test rats throughout the 24 
hours of administration of the extract up to a dose 
of 5000mg/Kg. This indicated that ethanol extract 
of the stem bark of C. febrifuga was 
physiologically safe to the test rats; suggestive that 
it will reduce the risk posed by synthetic drugs to 
humans. 
Hyperglycemia is an important 
pathophysiological characteristic of diabetes 
mellitus. It is a condition that is characterized by 
persistent high level of unmetabolised sugar in the 
blood that could eventually lead to diabetic 
condition (Goldberg, 2018).  
Alloxan, a β- cytotoxin induces diabetes 
mellitus by damaging the insulin secreting β- cells 
of the pancreas resulting in decreased endogenous 
insulin release (Rajagopal and Sasikala, 2008). 
Consequently, intrapertoneal 
administration of alloxan (150mg/kg) in the test 
rats effectively induced them and this was used to 
explore the scientific basis of the ethanol stem bark 
extract of C. febrifuga for correction of 
hyperglycemia in diabetes mellitus.  
Oral treatment of diabetic rats with 
ethanol stem bark extract of C. febrifuga gave a 
promising results as shown in Table 3. The result 
showed that the extract significantly (p<0.05) 
reduced the blood glucose level in all the treated 
groups (Groups C, D and E) compared to the rats in 
the diabetic control group (Group B). The 
1000mg/kg dose showed a significant reduction of 
the blood glucose level after day 5 of treatment 
(with a total reduction of 46.53%). A significant 
reduction in the blood glucose level was also 
observed in the diabetic rats treated with 500mg/kg 
and 1500mg/kg extract starting from day 2 and day 
6 respectively. These results were significantly 
different compared to the diabetic control group 
which shows a continuous rise in the glucose level. 
The effect of the extract at all of these doses is also 
comparable to the standard antidiabetic drug 
(glibenclamide) which showed significant 
hypoglycemic effect as from day 5 (Table 3). The 
most interestingly was the result obtained from 
treatment at 500mg/kg extract, with significant 
hypoglycemic effect from day 2. This dose gave 
the best result and is favourably compared to the 
standard drug, with a marked reduction in at day 5 
by 56.31% as against 28.35% respectively.  
Oral hyperglycemic agents (or 
pharmaceutical agents) such as sulphonylureas, 
meglitimide, insulin, thiazolidinedione, sodium 
glucose cotransporter inhibitors among others are 
used to manage diabetes mellitus. However, these 
are without some serious risk factors to be 
considered such as efficacy, cost, side effect, 
weight gain, cormorbidities and hypoglycemia. For 
instance, sulphonylureas lead to hypoglycemia, 
insulin injection causes hypokalemia and 
ketoacidosis is cause by the use of sodium glucose 
cotransporter inhibitors (Chaudaury et al. 2017).  
However, the use of medicinal plants in 
the management of diabetes mellitus has been 
encouraged (Shokeen et al. 2008). These medicinal 
plants contain rich phytochemicals (that improve 
pancreatic cells performance) and are relatively 
devoid of numerous disadvantages associated with 
pharmaceutical agents (Dey et al. 2002; Switi et al. 
2014). 
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Hyperlipidemia is another important 
consequence of diabetes mellitus. The condition is 
characterized by prolonged high concentration of 
lipid in the blood and is the leading cause of 
atherosclerosisis in diabetic patients (Goldberg, 
2018).  
Result of the effect of ethanol stem bark 
extract of C. febrifuga  on rats is presented in Table 
4. The result showed a slight increase in total 
triglyceride level, low density lipoprotein (LDL) 
cholesterol; a significant increase (p<0.05) in total 
cholesterol level and a slight decrease in the level 
of high density lipoprotein (HDL) of the diabetic 
rats compared to the normal control (non-diabetic 
rats). However, these parameters were reversed 
after treatment. Total Cholesterol and Triglyceride 
slightly decreased while LDL concentration 
decreased significantly (p<0.05) when compared to 
that of the diabetic control group (Group B). HDL 
increased in all the doses however, the increase was 
not significant as against the diabetic control. On 
percent scale, the HDL increased by 55.18% (at 
1000mg/kg) and the LDL reduced significantly by 
73.52% at the dose of 500mg/kg as against the 
standard drug which showed just 20.69% 
reduction. 
The significant increase in serum lipid 
profile of the diabetic rats is a consequence of the 
uninhibited actions of lipolytic hormones on the 
peripheral fat depots due to insulin defect. This 
condition led to high concentration of free fatty 
acids in the plasma which are subsequently 
converted to phospholipids and cholesterol by the 
liver. The two compounds with excess triglycerides 
are discharged into lipoprotein in the blood thus 
resulting to hyperlipidemia (Rajagopal and 
sasikala, 2008). Administration of ethanol extract 
of C. febrifuga stem bark reversed the above 
changes and improved the HDL levels. This result 
is tandem with that reported by Ojewale et al. 
(2014) on the root bark extract of the plant. 
 
CONCLUSION 
The results of the present investigation 
indicates that ethanol C. febrifuga stem bark extract 
have hypoglycemic effect on alloxan-induced 
diabetic rats. It was also found to be effective in 
managing hyperlipidemia. Therefore, C. febrifuga 
stem bark has a therapeutic property in the 
management of diabetes mellitus, and this justifies 
it used by folklore. Finally, work is on going 
towards investigating the antioxidant activity and 
isolating the bioactive compound(s) which is/are 
responsible for these effects of plant extract. 
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